The European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC) is a collaborative study involving pancreas specialists from throughout Europe.
There are two types of families EUROPAC is investigating, those which appear to have an inherited cause of pancreatitis and those which appear to have an inherited predisposition to pancreatic cancer. In addition to providing advice to patients and clinicians, we are gathering information and samples from members of these families in order to improve the scientific and clinical characterisation of hereditary pancreatic disease.
Some inherited pancreatic conditions have been shown to confer an increased risk of pancreatic cancer. At present there is no proven screening programme for pancreatic cancer. Given the importance of diagnosing pancreatic cancer at an early stage, EUROPAC has also developed a secondary screening study aimed at individuals deemed at an increased risk after a process of risk assessment.
EUROPAC is funded by a grant from the National Institute of Health Research (NIHR) via the Pancreas Biomedical Research Unit in Liverpool.